118 related articles for article (PubMed ID: 31989570)
1. Detection and Characterization of Oncogene Mutations in Preneoplastic and Early Neoplastic Lesions.
Minamoto T
Methods Mol Biol; 2020; 2102():419-437. PubMed ID: 31989570
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions.
Minamoto T
Methods Mol Biol; 2005; 291():263-78. PubMed ID: 15502229
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions.
Minamoto T
Methods Mol Biol; 2014; 1105():381-98. PubMed ID: 24623243
[TBL] [Abstract][Full Text] [Related]
4. Sampling method as a key factor in identifying K-ras oncogene mutations in preneoplastic colorectal lesions.
Ronai Z; Minamoto T; Butler R; Tobi M; Luo FQ; Zang E; Esumi H; Sugimura T
Cancer Detect Prev; 1995; 19(6):512-7. PubMed ID: 8925520
[TBL] [Abstract][Full Text] [Related]
5. K-ras mutations in putative preneoplastic lesions in human colon.
Pretlow TP; Brasitus TA; Fulton NC; Cheyer C; Kaplan EL
J Natl Cancer Inst; 1993 Dec; 85(24):2004-7. PubMed ID: 8246286
[TBL] [Abstract][Full Text] [Related]
6. K-ras and p53 mutations in human colorectal aberrant crypt foci.
Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
[TBL] [Abstract][Full Text] [Related]
7. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
8. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer.
Lev Z; Kislitsin D; Rennert G; Lerner A
J Cell Biochem Suppl; 2000; 34():35-9. PubMed ID: 10762013
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
10. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
Hu Y; Le Leu RK; Young GP
Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.
Thebo JS; Senagore AJ; Krygier S; Luchtefeld MA
Am Surg; 2001 Aug; 67(8):802-5. PubMed ID: 11510588
[TBL] [Abstract][Full Text] [Related]
12. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
13. A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.
Nishikawa T; Maemura K; Hirata I; Matsuse R; Morikawa H; Toshina K; Murano M; Hashimoto K; Nakagawa Y; Saitoh O; Uchida K; Katsu K
Clin Chim Acta; 2002 Apr; 318(1-2):107-12. PubMed ID: 11880119
[TBL] [Abstract][Full Text] [Related]
14. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
Nollau P; Moser C; Weinland G; Wagener C
Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
[TBL] [Abstract][Full Text] [Related]
15. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces.
Ratto C; Flamini G; Sofo L; Nucera P; Ippoliti M; Curigliano G; Ferretti G; Sgambato A; Merico M; Doglietto GB; Cittadini A; Crucitti F
Dis Colon Rectum; 1996 Nov; 39(11):1238-44. PubMed ID: 8918432
[TBL] [Abstract][Full Text] [Related]
16. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
[TBL] [Abstract][Full Text] [Related]
17. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.
Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
Gastroenterology; 1995 Feb; 108(2):434-40. PubMed ID: 7835585
[TBL] [Abstract][Full Text] [Related]
18. K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues.
Monstein HJ; Fransén K; Dimberg J; Söderkvist P
Eur J Clin Invest; 2004 Feb; 34(2):100-6. PubMed ID: 14764072
[TBL] [Abstract][Full Text] [Related]
19. Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples.
Ward R; Hawkins N; O'Grady R; Sheehan C; O'Connor T; Impey H; Roberts N; Fuery C; Todd A
Am J Pathol; 1998 Aug; 153(2):373-9. PubMed ID: 9708798
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa.
Jacoby RF; Llor X; Teng BB; Davidson NO; Brasitus TA
J Clin Invest; 1991 Feb; 87(2):624-30. PubMed ID: 1991846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]